Calcium carbonate and magnesium hydroxide in the prevention of renal osteodystrophy or the demise of aluminum toxicity in uremia. Analysis of 5 years experience.
D000328:Adult; D000535:Aluminum / Q000009:adverse effects / Q000378:metabolism; D002119:Calcium Carbonate / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000517:prevention & control; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use*; D008276:Magnesium Hydroxide / Q000627:therapeutic use*; D010710:Phosphates / Q000378:metabolism; D006435:Renal Dialysis; D014511:Uremia / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism
D010710:Phosphates; D000535:Aluminum; D002119:Calcium Carbonate; D008274:Magnesium; D008276:Magnesium Hydroxide